Article
Impact of CYP1A1, GSTM1, and GSTT1 polymorphisms in overall and specific prostate cancer survival.
Urologic oncology - 1 Apr 2014
Acevedo Cristián A, Quiñones Luis A, Catalán Johanna, Cáceres Dante D, Fullá Juan A, Roco Angela M
Abstract excerpt
OBJECTIVE: Prognostic biomarkers that distinguish between patients with good or poor outcome can be used to guide decisions of whom to treat and how aggressively. In this sense, several groups have proposed genetic polymorphisms as potential susceptibility and prognostic biomarkers; however, their validity has not been proven. Thus, the main goal of the present work was to investigate the potential role of single...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
